Lantern Pharma Inc. Common Stock LTRN
$3.93
-1.01%
at last close
Key Stats
- Today's Range
- $3.90 – $4.18
- 50-Day Range
- $1.96 – $4.34
- 52-Week Range
- $1.11 – $5.74
- Volume
- 105K shs
- Average Volume
- 206K shs
- Market Cap
- $50.14 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 14.55
- Price / Sales
- —
Short Interest
- Short Interest
- 0.21%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-15,911,826
- Net Margin
- —
- Return on Equity
- -461.79%
- Debt-to-Equity
- —
About Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.